parallax background

Transforming and innovating the
Medicinal Cannabis industry to
generate substantial and positive
changes to the patients' lives.

Transforming and innovating the Medicinal Cannabis industry to generate substantial and positive changes to the patients' lives.

European based, science driven medical cannabis company, committed to producing high quality, personalized medicine. Positioned at the crossroads of biotechnology, neuroscience, and medicinal cannabis.

Created in 2019, Piahuy Labs received the pre-licence from the Infarmed - Portuguese National Authority of Medicines and Health Products, in 2020.

ABOUT PIAUHY

European based, science driven medical cannabis company, committed to producing high quality, personalized medicine. Positioned at the crossroads of biotechnology, neuroscience, and medicinal cannabis.

Created in 2019, Piahuy Labs received the pre-licence from the Infarmed - Portuguese National Authority of Medicines and Health Products, in 2020.

ABOUT PIAUHY

RESEARCH | R&D

Research is led by our Scientific Committee including collaborations with leading universities and biotech companies from Brazil, California, Portugal and Switzerland.


 
alt-text
Epilepsy
alt-text
Autism
alt-text
Alzheimer
 
KNOW MORE

RESEARCH | R&D

Research is led by our Scientific Committee including collaborations with leading universities and biotech companies from Brazil, California, Portugal and Switzerland.


3

CANNABIS APPLICATIONS

alt-text
Epilepsy
alt-text
Autism
alt-text
Alzheimer
KNOW MORE

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

Invest in Piauhy

The Medical Cannabis company of the future

Piauhy is a multinational biotech pharma company that is patient's driven and focused on high end EU GMP Pharma Certified medicinal cannabis products.

Invest today

Commercial Alliance

Let's grow together

We can support your commercial needs all over the world, contact us to know about our products and services and to leverage your market opportunities.

Get in touch

NEWS

NEWS

December 3, 2021
December 3, 2021
Categories

Parkinson’s disease and cannabinoids

Parkinson’s disease (PD) is a neurodegenerative brain disorder that affects the production of dopamine. PD symptoms appear progressively by manifesting less motor control and patients may […]
Do you like it?
Read more
November 20, 2021
November 20, 2021
Categories

Menopause symptoms and treatments | Benefits of cannabis for women’s health

Menopause is a natural transition in women’s life associated with body and hormone imbalances. Some of them can be uncomfortable experiences (such as hot flashes, insomnia, […]
Do you like it?
Read more
November 12, 2021
November 12, 2021
Categories

Psoriasis Disease and the Cannabis sativa

Psoriasis is a chronic inflammatory skin disease that is characterized by the differentiation of keratinocyte dysregulation, but oxidative stress also plays an important role in the […]
Do you like it?
Read more

OUR ECOSYSTEM

OUR ECOSYSTEM

 
1.jpg
logo_UA
UAi_halternativa_designacao_1555075011702
 
Investor